Getting latest data loading
Home / Blog / blog / Kraft Heinz Unilever: A marmite deal?

This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.

Kraft Heinz Unilever: A marmite deal?

We are blessed with a whirlwind of exciting M&A news at the moment. At the risk of being a party pooper, however, I have reservations about the latest between Kraft-Heinz and Unilever. Yes the latter has rejected a merger offer, but that’s par for the course in takeover negotiations. Rarely is a first approach accepted. If someone is that interested, they’ll be back with a better offer. Which Kraft may well do, as it says it wants to “work towards an agreement” and especially with a mere 18% premium offered being well shy of the 30% average for big deals over the last few years. A 14% Unilever share price jump to fresh all-time highs is thus understandable today, on hopes of a better deal being forthcoming before a 17 March (5pm) ‘put up or shut up’ deadline according to UK takeover rules.

kraft heinz Unilever

US giant Kraft Heinz has made a merger offer to fellow consumer giant Unilever which would result in one of the biggest groups in the world selling over 400 consumer/household goods to over a third of mankind. Synergies may well be significant and could help offset myriad headwinds (FX, rising commodity prices, regulations, declining sales), but simply on size alone anti-competition hurdles would surely be even more so, not just in Europe but round the world given both groups’ geographic reach. And their size means the deal could be one of the longest to get approval in history.

Kraft (pre-Heinz, pre-2015) also has form in the UK, of the negative type. In 2010 it gobbled up Cadbury, making assurances about job security which were ultimately and almost immediately ignored, a plant closure being blamed  on ‘economic reasons’ (krafty). New rules mean much more information required about a buyer’s intentions from the word go. And the last government has already intervened since to prevent US Pharma giant Pfizer buying out the UK’s own AstraZeneca.

However, in terms of political hurdles it could still be a case of once bitten, twice shy. Theresa May will surely baulk at an opportunistic pounce being made thanks to a Brexit-induced weak GBP making this deal 15% cheaper than it would have been a year ago. Note that a 15% dscount plus the 18% premium makes 33%, much closer to the average premium for ceding control and what the Unilever board would likely want to take to its shareholders, if the board is even interested at all.

Elsewhere on the political front, don’t forget that Unilever is British-Dutch and both nations face major headwinds. The UK is edging towards Brexit and Theresa May would surely like to be seen protecting UK jobs and interests. In the Netherlands there is potential to see Geert Wilders’ Party for Freedom deliver a Trump-like populist win that takes the nation down a similarly anti-immigration and protectionist path, perhaps even more severely. Note that the aforementioned 17 March deadline for a firm and final offer (can be extended under certain circumstances) is just a week after Theresa May would like to trigger article 50 at an EU summit. It is also just two days after the Dutch go to the polls.

This deal may prove less about finances, synergies and corporate merit, and rather more so about politics and competitive hurdles. Don’t forget Europe also faces calls from several member nations to prevent the Chinese from snapping up significant European companies, stealing know-how. The new US president would agree about such a protectionist stance, he is after all demanding that US companies bring back production to within US borders. It’s what got him elected. Unless of course it proves yet another case of one rule for them, and another for us? It’s unlikely this deal can be packaged up quickly, destined to be termed a ‘marmite offer’ – not to everyone’s taste.

That said, the shares could still make a foray above £40 (+8%) on hopes of a better deal and any favourable political spiel. The likelihood is though that the situation represents a short-term trade rather than a long-term opportunity.

This type of analysis is what you can expect from Accendo Markets on a daily basis. We are here to digest and filter news flow to help you decide where markets are headed, be it for shares, indices, commodities or currencies. If you like what you have read and fancy doing so permanently get access here. We’re sure you won’t regret it.

Enjoy your weekend!

Mike van Dulken, Head of Research, 17 Feb 2017

« Back to Category

This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.

Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance. Prepared by Michael van Dulken, Head of Research

Comments are closed.

Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage.
Spread bets and CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 67% of retail investor accounts lose money when spread betting and/or trading CFDs with this provider. You should consider whether you understand how spread bets and CFDs work and whether you can afford to take the high risk of losing your money.
.